|
|
| |
|
|
| |
ABSTRACT |
|
| |
|
|
| |
To establish the cause of reduction in hip and waist circumferences experienced by participants of
the Slimaluma™ human clinical study the following studies were made: |
|
| |
|
|
| |
|
Part I : Anti-obesigenic property of Caralluma fimbriata extract (Slimaluma™) in the rat |
| |
model – Slimaluma™ prevents the rats from becoming obese |
|
Part II : Leptin Level study – Leptin level reduced by 4.1% compared to
raise of 293% in |
| |
placebo |
|
Part III : Cell Line study – Reduction in grown of pre-adipocytes by 35% |
| |
|
|
|
| |
|
|
| |
|
|
|
|
